Autopsy report · NCT01011686

Safety Study of Autologous Cultured Adipose -Derived Stem Cells for the Fecal Incontinence

“Few subject enrolled”

The sponsor’s own words in the registry.

Life of this trial

• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Anterogen Co., Ltd.

Sponsor type

Industry

Conditions

Fecal Incontinence

Interventions

ANT-SM

Sites

1

Countries

South Korea

Trials that died the same way

• Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections
  “Subject Enrollment” (78% match in meaning)
• Vancomycin Treatment in Recurrent PSC in Liver Transplant Patients
  “0 subjects enrolled” (77% match in meaning)
• Effectiveness Study of Santyl Ointment to Treat Pressure Ulcers
  “Low enrollment of qualified subjects” (77% match in meaning)
• Bilateral Thoracoscopic Splanchnicectomy for Pain Relief in Patients With Unresectable Pancreatic Cancer
  “no subjects enrolled” (75% match in meaning)
• Evaluation of a Combined Near Infrared Spectroscopy (NIRS) and Intravascular Ultrasound (IVUS) Catheter for Detection of Lipid Rich Plaque
  “It was felt that a sufficient number of subjects were enrolled.” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.